Clinical Trial Detail

NCT ID NCT03164057
Title A Trial of Epigenetic Priming in Patients With Newly Diagnosed Acute Myeloid Leukemia
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements yes
Sponsors St. Jude Children's Research Hospital
Indications

acute myeloid leukemia

myeloid leukemia

myelodysplastic syndrome

myeloid sarcoma

Therapies

Etoposide

Filgrastim

Dexrazoxane

Daunorubicin

Idarubicin

Fludarabine

Asparaginase

Cytarabine

Sorafenib

Mitoxantrone

Decitabine

Azacitidine

Age Groups: adult child

Additional content available in CKB BOOST